FB-1603

· Febico Biomedical Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FB-1603, covering 2025-02-27 to 2025-02-27. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization [Phase 1, Phase 2]

See pricing